Benchmark is strengthening its board of directors, bringing in Hugo Wahnish and former SalMar CEO Yngve Myhre as non-executive directors of the company with immediate effect.

Wahnish has more than 35 years of experience in the animal health and pharmaceuticals industry, firstly with GlaxoSmithKline, and more recently with Merck.

He held the post of chief commercial officer animal health at Merck, having responsibility for Merck's commercial operations worldwide.

Since stepping down from that role in 2012, he has acted as an independent senior advisor with several multinational companies, private equity groups and consulting firms primarily in the animal health sector.